Cantor Fitzgerald just dropped $2 billion into a new Bitcoin lending business. That move alone shoved the whole crypto ...

On Monday, Cantor Fitzgerald analyst reiterated an ... a current ratio of 20.14 and holds more cash than debt on its balance sheet. A significant milestone highlighted during the conference ...

On Friday, Cantor Fitzgerald reaffirmed an Overweight ... current ratio of 1.92 and holds more cash than debt on its balance sheet, though it’s currently experiencing rapid cash burn.

On Monday, Cantor Fitzgerald analyst reiterated an Overweight rating ... position with a current ratio of 20.14 and holds more cash than debt on its balance sheet. A significant milestone highlighted ...

On Friday, Cantor Fitzgerald reaffirmed an Overweight rating on GlycoMimetics ... maintains a healthy current ratio of 1.92 and holds more cash than debt on its balance sheet, though it’s currently ...

Discover Ouster's Q4 2024 earnings insights: record revenue, strategic growth in smart infrastructure & robotics, and plans to drive profitability.

Q4 2024 Earnings Call Transcript March 20, 2025 ARS Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.52, ...

Institutional investors and professional traders rely on The Fly to keep up-to-the-second on breaking news in the electric vehicle and clean ...

Q4 2024 Management View CEO Jeffrey Graves emphasized the impact of a change in accounting estimate for the regenerative medicine program, which resulted in a $9 million reduction in Q4 revenue. He ...

On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of ...

On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of therapeutic dosing of potential new medicine, all based on our ...